Search

Your search keyword '"Fischell, T."' showing total 105 results

Search Constraints

Start Over You searched for: Author "Fischell, T." Remove constraint Author: "Fischell, T."
105 results on '"Fischell, T."'

Search Results

3. Edoxaban versus warfarin in patients with atrial fibrillation

4. Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial

5. Ezetimibe added to statin therapy after acute coronary syndromes

6. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)

7. Cardioversion of Atrial Fibrillation in ENGAGE AF-TIMI 48

8. Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)

9. Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48

10. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

33. Quantitative angiographic outcome after intracoronary pullback atherectomy.

35. Management of Atrial Fibrillation Post Transcatheter Aortic Valve Implantation.

36. Shockwave Lithotripsy of Calcific Stenosis of the Distal Abdominal Aorta to Facilitate Transcatheter Aortic Valve Replacement.

37. Evaluation of Transcatheter Alcohol-Mediated Perivascular Renal Denervation to Treat Resistant Hypertension.

38. Implanted Monitor Alerting to Reduce Treatment Delay in Patients With Acute Coronary Syndrome Events.

39. Eptifibatide: The evidence for its role in the management of acute coronary syndromes.

40. Coronary embolization following balloon dilation of lipid-core plaques.

41. Sirolimus-eluting stents for treatment of complex bypass graft disease: insights from the SECURE registry.

42. Intragraft nicardipine prophylaxis to prevent no-reflow in triple-vessel saphenous vein graft intervention.

43. IAGS proceedings. The biology of plaque and patient vulnerability. Panel discussion.

44. Intracoronary brachytherapy in the porcine model: a different animal.

45. Overestimation of stent delivery balloon diameters by manufacturers' compliance tables: a quantitative coronary analysis of Duet and NIR stent implantation.

46. Visible stents: all that glitters...is it gold?

47. Ultrasound thrombolysis for the treatment of thrombotic occlusion of degenerated saphenous vein grafts.

48. The impact of stent design and delivery upon the long-term efficacy of radioisotope stents.

49. Effect of glycoprotein IIb/IIIa inhibition without thrombolytic therapy on reperfusion in acute myocardial infarction: results of ReoMI pilot study.

Catalog

Books, media, physical & digital resources